De Giorgi, Riccardo http://orcid.org/0000-0001-5984-8696
De Crescenzo, Franco
Cowen, Philip J.
Harmer, Catherine J.
Cipriani, Andrea
Funding for this research was provided by:
Wellcome Trust (216452/Z/19/Z)
National Institute for Health and Care Research (RP-2017-08-ST2-006)
Article History
Received: 6 May 2023
Accepted: 30 October 2023
First Online: 7 November 2023
Declarations
:
: This study has been independently reviewed and approved by the QResearch scientific committee: 18/EM/0400. To obtain consent to provide data, QResearch uses the Egton Medical Information Systems, a major supplier of primary care computer systems commissioned for most general practices across the country.
: Not applicable.
: PJC was supported by the Medical Research Council (MRC) (grant MR/S003037/1, title “Clinical Psychopharmacology of Depression”). CJH was supported by the NIHR Oxford Health Biomedical Research Centre; she has received consultancy fees from P1vital, Lundbeck, Servier, UCB, Zogenix, J&J, and Syndesi outside of the current work. AC was supported by the National Institute for Health Research (NIHR) Oxford Cognitive Health Clinical Research Facility, by an NIHR Research Professorship (grant RP-2017–08-ST2-006), by the NIHR Oxford and Thames Valley Applied Research Collaboration, and by the NIHR Oxford Health Biomedical Research Centre (grant NIHR203316); he has received research and consultancy fees from INCiPiT (Italian Network for Paediatric Trials), CARIPLO, Lundbeck and Angelini Pharma outside of the current work. The other authors declare that they have no conflict of interest. The views expressed are those of the authors and not necessarily those of the Wellcome Trust, the NIHR, the MRC, the UK NHS, or the UK Department of Health.